Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Intangible Assets
Prestige Consumer Healthcare Inc
Intangible Assets Peer Comparison
Competitive Intangible Assets Analysis
Latest Figures & CAGR of Competitors
Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Intangible Assets
$2.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
Johnson & Johnson
NYSE:JNJ
|
Intangible Assets
$34.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Intangible Assets
$32.8B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
100%
|
CAGR 10-Years
31%
|
|
Pfizer Inc
NYSE:PFE
|
Intangible Assets
$64.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
14%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Intangible Assets
$17.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-2%
|
|
Eli Lilly and Co
NYSE:LLY
|
Intangible Assets
$6.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
See Also
What is Prestige Consumer Healthcare Inc's Intangible Assets?
Intangible Assets
2.3B
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Intangible Assets amounts to 2.3B USD.
What is Prestige Consumer Healthcare Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
5%
Over the last year, the Intangible Assets growth was -13%. The average annual Intangible Assets growth rates for Prestige Consumer Healthcare Inc have been -2% over the past three years , -3% over the past five years , and 5% over the past ten years .